Toggle menu
Toggle preferences menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

Page values for "Testosterone"

From Pharmacopedia
More actions

"Medicines" values

1 row is stored for this page
FieldField typeValue
genericStringTestosterone
brandStringAndroGel, Testim, Axiron, Fortesta (gels); Androderm (patch); Aveed (IM); Striant (buccal); Natesto (nasal); Jatenzo, Tlando (oral undecanoate)
structureFile
classesList of String, delimiter: ,Androgen / Anabolic Steroid
mechanismStringEndogenous androgen binding to androgen receptors; mediates male secondary sex characteristics, anabolism, libido, erythropoiesis, and CNS effects on mood/energy/aggression. Aromatized peripherally to estradiol; reduced to DHT.
usesString'"`UNIQ--vote-00000758-QINU`"', '"`UNIQ--vote-00000759-QINU`"', '"`UNIQ--vote-0000075A-QINU`"'
starting_doseStringFormulation-dependent. Gels: 40–50 mg topically daily. Cypionate/enanthate IM: 50–100 mg weekly. Undecanoate IM: 750 mg q10w. Patch: 4 mg/d.
preparationsStringGels, patches, IM cypionate/enanthate/undecanoate, buccal tabs, nasal gel, oral undecanoate, subcutaneous pellets
fda_maxStringFormulation-dependent
pill_idText
routesList of String, delimiter: ,Topical (gel/patch) IM buccal nasal oral (undecanoate only)
onsetStringHours (transdermal); days (IM esters)
durationStringHours (nasal); ~24 h (gel/patch); 1–2 weeks (cypionate/enanthate IM); ~10 weeks (undecanoate IM)
halflifeStringHighly variable by formulation; native T is hours
bioavailabilityStringOral non-undecanoate has essentially zero bioavailability (hepatic first-pass)
pregnancyStringCategory X, contraindicated; teratogenic (virilization of female fetus)
legalStringSchedule III (DEA, US)